Highlights –
- Pharmaceutical giant Celltrion makes operating profit
- Biosimilars in demand
- Company aims to add 46 more new drugs by 2022
South Korean pharmaceutical giant and leading drug maker Celltrion Inc. have made a consolidating operating profit in the year-end quarter of 2019. The company made a double profit in sales in comparison to its fourth-quarte....
Tags : CELLTRION, PHARMACEUTICALS, OPERATING PROFIT, BIOSIMILARS,
comments (0)